SAVA TECHNOLOGIES LTD.
Company number 10500092 · Monitor this company
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£16,499,529
Balance sheet as at 2025-03-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-11-28
- Employees
- 40 (2025 accounts · was 34 in 2024)
- Registered office
- 117 Charterhouse Street, London, England, EC1M 6AA
- Postcode
- EC1M 6AA
- Capital
- 4 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-03-30
- Next due by
- 2026-12-30
- Financial year end
- 30 March
Confirmation statement
- Last statement dated
- 2025-03-13
- Next due by
- 2026-03-27 Overdue
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
- 86900 Other human health activities
Officers 5 current
Previous company names
| Name | Date changed |
|---|---|
| HONE HEALTH LTD. | 2021-06-09 |
| CAURA.ME LTD | 2020-10-16 |
| CORTICARE LIMITED | 2019-01-31 |
Previous registered addresses 4
| Address | Changed on |
|---|---|
| 41 CORSHAM STREET, LONDON, N1 6DR, ENGLAND | 2021-01-07 |
| 41 CORSHAM ST CORSHAM STREET, LONDON, LONDON, N1 6DR, ENGLAND | 2019-09-18 |
| FLAT 7 3 ELVERTON STREET, ROYAL WESTMINSTER LODGE, LONDON, SW1P 2QW, UNITED KINGDOM | 2019-09-13 |
| FLAT 365, 300 VAUXHALL BRIDGE ROAD, LONDON, SELECT, UNITED KINGDOM | 2017-05-24 |
Among its peers
Top 5%
by shareholders' funds, of 139 similar companies in EC
3rd largest employer among its local peers (40 staff).
Among the oldest 25% of its local peers, trading since 2016.
No.3 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 3 among research and experimental development on biotechnology in London.
The class of 2016
36%
of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.